Literature DB >> 23612386

Role of NOS3 DNA variants in externalizing behavioral problems observed in childhood leukemia survivors.

Sophie Marcoux1, Philippe Robaey, Annabel Gahier, Malgorzata Labuda, Julie Rousseau, Daniel Sinnett, Albert Moghrabi, Caroline Laverdière, Maja Krajinovic.   

Abstract

OBJECTIVE: Neuropsychological problems occurrence varies among childhood cancer survivors, and associated risk factors have not been fully deciphered. We wanted to study the role of genetic variants in behavioral problems in this population. STUDY
DESIGN: Behavioral problems in pediatric acute lymphoblastic leukemia patients (n=138) were investigated longitudinally, using the Child Behavior Checklist questionnaire and multilevel statistical modeling. Thirty-four candidate polymorphisms, related to anticancer drug effects, were investigated.
RESULTS: NOS3 gene functional polymorphisms showed significant association: patients homozygous for the minor allele at investigated loci showed decreased externalizing behavioral problems scores over time (t tests: T-786C n=69, P=0.003; G894T n=71, P=0.065). The effect was even more pronounced for individuals that are homozygous for the -786C844T haplotype (t test, n=69, P<0.001) and results were supported by multilevel modeling analyses (P<0.001). No such association was observed for internalizing behavioral problems.
CONCLUSION: NOS3 variants modulate externalizing problems individual trajectories, likely in relationship with glucocorticoid exposure.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23612386     DOI: 10.1097/MPH.0b013e31828e518d

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  3 in total

1.  Neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: A systematic review.

Authors:  Yin Ting Cheung; Kevin R Krull
Journal:  Neurosci Biobehav Rev       Date:  2015-04-07       Impact factor: 8.989

Review 2.  Current and coming challenges in the management of the survivorship population.

Authors:  Eric J Chow; Kirsten K Ness; Gregory T Armstrong; Nickhill Bhakta; Jennifer M Yeh; Smita Bhatia; Wendy Landier; Louis S Constine; Melissa M Hudson; Paul C Nathan
Journal:  Semin Oncol       Date:  2020-03-04       Impact factor: 4.929

3.  Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia.

Authors:  M Krajinovic; J Elbared; S Drouin; L Bertout; A Rezgui; M Ansari; M-J Raboisson; S E Lipshultz; L B Silverman; S E Sallan; D S Neuberg; J L Kutok; C Laverdière; D Sinnett; G Andelfinger
Journal:  Pharmacogenomics J       Date:  2015-09-08       Impact factor: 3.550

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.